This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma Limited. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Bernard Yvon Jack Vacher: Innovator in Pharmaceutical Compounds
Introduction
Bernard Yvon Jack Vacher is a notable inventor based in Dagenham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential therapeutic applications.
Latest Patents
Vacher holds a patent for "Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic-or heteroatom-containing linking group." This invention focuses on the pharmaceutical use of phenyl compounds that are linked to an aryl moiety through various linkages. The compounds are designed for inhibiting tumor necrosis factor and cyclic AMP phosphodiesterase. His innovative work in this area has the potential to impact the treatment of various diseases.
Career Highlights
Bernard Yvon Jack Vacher is associated with Aventis Pharma Limited, where he has been involved in groundbreaking research and development. His expertise in pharmaceutical compounds has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Vacher has collaborated with notable colleagues, including Michael John Ashton and David Charles Cook. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Bernard Yvon Jack Vacher's contributions to pharmaceutical innovations highlight his role as a key inventor in the field. His work continues to pave the way for new therapeutic options and demonstrates the importance of research in improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile